Dual-substrate specific PDE inhibitors, in particular PDE3 inhibitors, are also currently receiving a lot of interest [35,61], especially after the discovery that increase of cGMP can reduce oxidative stress in COPD [62]. The gene discussed is ALDH7A1; the disease is chronic obstructive pulmonary disease.